how glp 1 medications are changing consumer behavior GLP-1 GLP-1 Trends: Costs & Coverage
Description
According to the World Health Organization (WHO), the number of obese individuals worldwide has nearly tripled since 1975
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: Single-arm, open-label, multicentre, phase 3 trials
I want to respect that there's a diversity of reasons why people come to body positivity
While it helps regulate energy balance and can mimic the effects of caloric restriction(1), it is a complex molecule to manage
